Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 613-621

  Stephans, Stacy E ^a   Whittingham, Tim S ^a   Douglas, Albertina J ^a   Lust, W David ^a   Yamamoto, Bryan K ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Dopamine; Energy metabolism; Glutamate; Methamphetamine; Neurotoxicity; Striatum

Indexed keywords

DOPAMINE; GLUTAMIC ACID; METHAMPHETAMINE; NICOTINAMIDE; UBIQUINONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ENERGY METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NERVE CELL STIMULATION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031782828     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020613.x     Document Type: Article

References (54)

1. Abekawa T., Ohmori T., and Koyama T. (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281.
2. Bannon M. J. and Roth R. H. (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35, 53-68.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Cao C. J., Eldefrawi A. T., and Eldefrawi M. E. (1990) ATP-regulated neuronal catecholamine uptake: a new mechanism. Life Sci. 47, 655-667.
5. Carafoli E. (1987) Intracellular calcium homeostasis. Annu. Rev. Biochem. 56, 395-433.
6. Chan P., Di Monte D. A., Luo J.-J., DeLanney L. E., Irwin I., and Langston J. W. (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62, 2484-2487.
7. Cubells J. F., Rayport S., Rajendran G., and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
8. 2+ responses in rat primary astrocyte cultures. J. Neurosci. Res. 35, 246-256.
9. Delle Donne K. T. and Sonsalla P. K. (1994) Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. J. Pharmacol. Exp. Ther. 271, 1320-1326.
10. Donzanti B. A. and Yamamoto B. K. (1988) An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 43, 913-922.
11. Dragovic J., Kim S. H., Brown S. L., and Kim J. H. (1995) Nicotinamide pharmacokinetics in patients. Radiother. Oncol. 36, 225-228.
12. Estler C.-J. and Ammon H. P. T. (1967) The influence of propranolol on the methamphetamine-induced changes of cerebral function and metabolism. J. Neurochem. 14, 799-805.
13. Farfel G. M. and Seiden L. S. (1995) Role of hypothermia in mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272, 868-875.
14. Giovanni A., Liang L. P., Hastings T. G., and Zigmond M. J. (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64, 1819-1825.
15. Glinka Y., Tipton K. F., and Youdim M. B. H. (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66, 2004-2010.
16. Henneberry R. C., Novelli A., Cox J. A., and Lysko P. G. (1989) Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons, Ann. NY Acad. Sci. 568, 225-233.
17. 3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: an autoradiographic study. Neurosci. Lett. 65, 177-182.
18. Hotchkiss A. J. and Gibb J. W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-262.
19. Hotchkiss A. J., Morgan M. E., and Gibb J. W. (1979) The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25, 1373-1378.
20. Huang N.-K., Wan F.-J., Tseng C.-J., and Tung C.-S. (1997) Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats. Neuroreport 8, 1883-1885.
21. Kondo T., Ito T., and Sugita Y. (1994) Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. NY Acad. Sci. 738, 222-229.
22. LaManna J. C., Sylvia A. L., Martel D., and Rosenthal M. (1976) Fluorometric monitoring of the effects of adrenergic agents on oxidative metabolism in intact cerebral cortex. Neuropharmacalogy 15, 17-24.
23. Lewis J. J. and Van Petten G. R. (1962) The effect of amphetamine and related compounds on the concentration of adenine nucleotides, inorganic phosphate and creatine phosphate in the rat brain. J. Pharmacol. Exp. Ther. 136, 372-377.
24. Nahorski S. R. and Rogers K. J. (1973) In vivo effects of amphetamine on metabolites and metabolic rate in rat brain. J. Neurochem. 21, 679-686.
25. Nash J. F. and Yamamoto B. K. (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
26. Novelli A., Reilly J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
27. O'Dell S. J., Weihmuller F. B., and Marshall J. F. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
28. 2 antagonists. J. Neurochem. 60, 1792-1799.
29. Passonneau J. V. and Lowry O. H. (1993) Enzymatic Analysis - A Practical Guide. Humana Press, Totowa, New Jersey.
30. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando.
31. 2A receptor. Brain Res. 680, 9-15.
32. Pontieri F. E., Crane A. M., Seiden E. S., Kleven M. S., and Porrino E, J. (1990) Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology 102, 175-182.
33. Porrino E. J., Eucignani G., Dow-Edwards D., and Sokoloff L. (1984) Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res. 307, 311-320.
34. Raiteri M., Cerrito F., Cervoni A. M., and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195-202.
35. Ricaurte G. A., Guillery R. W., Seiden E. S., Schuster C. R., and Moore R. Y. (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235, 93-103.
36. Ricaurte O.A., Seiden E. S., and Schuster C. R, (1984) Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res. 303, 359-364.
37. +-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis. J. Pharmacol. Exp. Ther. 245, 858-866.
38. Rutledge C. O. (1978) Effect of metabolic inhibitors and ouabain on amphetamine- and potassium-induced release of biogenic amines from isolated brain tissue. Biochem. Pharmacol. 27, 511-516.
39. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R., and Gibb J.W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
40. Schraufstatter I. U., Hyslop P.A., Hinshaw D. B., Spragg R. G., Sklar E. A., and Cochrane C. G. (1986) Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly-(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 83, 4908-4912.
41. Schulz J. B., Matthews R. T., Henshaw D. R., and Beal M. F. (1996) Neuroprotective strategies for the treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71, 1043-1048.
42. Seiden E. S., Fishman M. W., and Schuster C. R. (1975/76) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1, 215-219.
43. Stephans S. E. and Yamamoto B. K. (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17, 203-209.
44. Stephans S. E. and Yamamoto B. K. (1996) Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 700, 99-106.
45. Sylvia A. L., LaManna J. C., Rosenthal M., and Jobsis F. F. (1977) Metabolite studies of methamphetamine effects based upon mitochondrial respiratory state in rat brain. J. Pharmacol. Exp. Ther. 201, 117-125.
46. Tsacopoulos M. and Magistretti P. J. (1996) Metabolic coupling between glia and neurons. J. Neurosci. 16, 877-885.
47. Wagner G. C., Ricaurte G. A., Seiden L. S., Schuster C. R., Miller R. J., and Westley J. (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181, 151-160.
48. Wechsler L. R., Savaki H. E., and Sokoloff L. (1979) Effects of d- and t-amphetamine on local cerebral glucose utilization in the conscious rat. J. Neurochem. 32, 15-22.
49. Wilson G. L., Patton N. J., McCord J. M., Mullins D. W., and Mossman B. T. (1984) Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells. Diabetologia 27, 587-591.
50. Yamamoto B. K. and Davy S. (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. Neurochem. 58, 1736-1742.
51. Yamamoto B. K. and Pehek E. A. (1990) A neurochemical heterogeneity of the rat striatum as measured by in vivo electrochemistry and microdialysis. Brain Res. 506, 236-242.
52. Yamamoto B. K. and Zhu W. (1997) Methamphetamine, free radicals and the production of oxidative stress. Soc. Neurosci. Abstr. 23, 2141.
53. Zeevalk G. D. and Nicklas W. J. (1990) Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253, 1285-1292.
54. Zhang J., Dawson V. L., Dawson T. M., and Snyder S. H. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687-689.